Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · women with endometriosis, following complete surgical excision of lesions
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ pelvic pain · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ pelvic pain compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ ovarian cyst · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ ovarian cyst compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects: headache · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ headache compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ migraine · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ migraine compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ depression · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ depression compared with placebo (very low certainty).
1 finding from 1 review
Biopsy‐proven recurrence of endometriosis · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes biopsy‐proven recurrence of endometriosis compared with placebo (very low certainty).
1 finding from 1 review
Quality of life: change in symptom severity score · women with uterine fibroids
1 finding from 1 review
Abnormal uterine bleeding: amenorrhoea · uterine fibroids
SPRM showed no clear difference in abnormal uterine bleeding: amenorrhoea compared with leuprolide acetate (moderate certainty).
1 finding from 1 review
Pelvic pain · uterine fibroids
1 finding from 1 review
Adverse effects: SPRM‐associated endometrial changes · uterine fibroids
SPRM probably leads to higher adverse effects: SPRM‐associated endometrial changes compared with leuprolide acetate (moderate certainty).
1 finding from 1 review
Quality of life: change in health‐related quality of life score · women with uterine fibroids
1 finding from 1 review
Abnormal uterine bleeding: change in menstrual blood loss · women with uterine fibroids
1 finding from 1 review
Abnormal uterine bleeding: amenorrhoea · women with uterine fibroids
SPRM probably leads to higher abnormal uterine bleeding: amenorrhoea compared with placebo (moderate certainty).
1 finding from 1 review
Pelvic pain · women with uterine fibroids
1 finding from 1 review
Adverse effects: SPRM‐associated endometrial changes · women with uterine fibroids
SPRM may leads to higher adverse effects: SPRM‐associated endometrial changes compared with placebo (low certainty).
1 finding from 1 review
Quality of life: change in symptom severity score · uterine fibroids
1 finding from 1 review
Quality of life: change in health‐related quality of life score · uterine fibroids
1 finding from 1 review
Abnormal uterine bleeding: change in menstrual blood loss · uterine fibroids
1 finding from 1 review
Intervention not reported
Moderate dose SSRI versus placebo Luteal or continuous administration · women with premenstrual syndrome
1 finding from 1 review